Key result
UCP3 insufficiency exacerbates LV diastolic dysfunction, concentric remodeling, and oxidative stress in hypertensive rats.
Why the study?
Does UCP3 insufficiency exacerbate left ventricular diastolic dysfunction during angiotensin II-induced hypertension in rats?
Does UCP3 insufficiency exacerbate left ventricular diastolic dysfunction during angiotensin II-induced hypertension in rats?
UCP3 insufficiency exacerbates left ventricular diastolic dysfunction during hypertension, supporting the potential use of mitochondria-targeted antioxidants as an adjuvant therapy for HFpEF in obesity.
Answers are grounded in this paper and cite their sources.
UCP3 insufficiency may worsen hypertensive diastolic dysfunction in rats; leaves open mitochondria-targeted antioxidants for human HFpEF.
rats. Histological and molecular analyses further revealed that UCP3 insufficiency accelerated left ventricular concentric remodeling, detrimental interstitial matrix remodeling, and fetal gene reprogramming during hypertension. Moreover, UCP3 insufficiency increased oxidative stress and led to greater impairment of protein kinase G signaling. Conclusions Our findings identified UCP3 insufficiency as a cause for increased incidence of left ventricular diastolic dysfunction during hypertension. The results add further support to the use of antioxidants targeting mitochondrial reactive oxygen species as an adjuvant therapy for preventing heart failure with preserved ejection fraction in individuals with obesity.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) studied Angiotensin II-induced hypertension. UCP3 insufficiency was evaluated on Left ventricular diastolic dysfunction and concentric remodeling. UCP3 insufficiency exacerbated left ventricular diastolic dysfunction, concentric remodeling, and oxidative stress during angiotensin II-induced hypertension in rats.
Synapse has enriched 10 related papers. Consider them for comparative context: